Helen Rizos

Macquarie University

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (22)

Collaborators (21)

Georgia Fisher

Russell Diefenbach

Macquarie University

Michael R. Eccles

University of Otago

Su Yin Lim

Macquarie University

Riccardo Dolcetti

Head, Clinical and Translational Immunotherapy

Peter MacCallum Cancer Centre

Alexander M. Menzies

University of Sydney

Gaston Arnolda

Macquarie University

Serigne N. Lô

John Park

Macquarie University

Sarah Kummerfeld

Garvan Institute of Medical Research

Brian Gabrielli

Elin Gray

Associate Professor

Edith Cowan University

Jordan Conway

University of Sydney

Peter M. Ferguson

Melanoma Institute Australia

Elena Shklovskaya

Macquarie University

Jenny Lee

Macquarie University

Richard Kefford

Macquarie University

Jessamy Tiffen

University of Sydney

Nana Lyu

Macquarie University

Ines Pires da Silva

Senior Lecturer

University of Sydney

Zhen Zeng

Helen Rizos

Research Interests

Explore related searches

Contact this professor

Articles (22)

Pre-Amplification of Cell-Free DNA: Balancing Amplification Errors with Enhanced Sensitivity

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma

Circulating MicroRNAs

A scoping review of factors influencing the implementation of liquid biopsy for cancer care

COP1 Deficiency in BRAF<sup>V600E</sup> Melanomas Confers Resistance to Inhibitors of the MAPK Pathway

Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy

Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma

Ex vivo tissue modelling informs drug selection for rare cancers

PKC-independent PI3K signalling diminishes PKC inhibitor sensitivity in uveal melanoma

Single-cell RNA sequencing in melanoma: what have we learned so far?

Size matters

Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors

Intratumoral CD16+ macrophages are associated with clinical outcomes of patients with metastatic melanoma treated with combination anti-PD-1 and anti-CTLA-4 therapy

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma

Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas

Durable responses to anti-PD1 and anti-CTLA4 in a preclinical model of melanoma displaying key immunotherapy response biomarkers

SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment

Protein-based classification of melanoma differentiation subtypes

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling

Comprehensive clinical, histopathologic, and molecular analysis and long-term follow-up of patients with nodal blue nevi

Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma

Collaborators (21)

Georgia Fisher

Russell Diefenbach

Michael R. Eccles

Su Yin Lim

Riccardo Dolcetti

Alexander M. Menzies

Gaston Arnolda

Serigne N. Lô

John Park

Sarah Kummerfeld

Brian Gabrielli

Elin Gray

Jordan Conway

Peter M. Ferguson

Elena Shklovskaya

Jenny Lee

Richard Kefford

Jessamy Tiffen

Nana Lyu

Ines Pires da Silva

Zhen Zeng

How do I reach out?

Meet Kite AI